TriaGen Wealth Management LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

TriaGen Wealth Management LLC purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 394 shares of the biotechnology company’s stock, valued at approximately $234,000.

Other institutional investors have also bought and sold shares of the company. Creative Planning boosted its position in Axon Enterprise by 9.6% during the second quarter. Creative Planning now owns 16,463 shares of the biotechnology company’s stock worth $4,844,000 after purchasing an additional 1,441 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Axon Enterprise by 30.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 802 shares of the biotechnology company’s stock valued at $236,000 after buying an additional 188 shares in the last quarter. EP Wealth Advisors LLC grew its stake in Axon Enterprise by 18.3% in the 2nd quarter. EP Wealth Advisors LLC now owns 1,577 shares of the biotechnology company’s stock valued at $464,000 after buying an additional 244 shares in the last quarter. Truist Financial Corp raised its holdings in Axon Enterprise by 53.4% during the 2nd quarter. Truist Financial Corp now owns 6,467 shares of the biotechnology company’s stock valued at $1,903,000 after acquiring an additional 2,251 shares during the period. Finally, Cetera Investment Advisers raised its holdings in Axon Enterprise by 11.8% during the 2nd quarter. Cetera Investment Advisers now owns 23,546 shares of the biotechnology company’s stock valued at $6,928,000 after acquiring an additional 2,479 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at $91,691,508.72. The trade was a 12.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 in the last 90 days. 6.10% of the stock is owned by company insiders.

Analyst Ratings Changes

AXON has been the subject of several recent research reports. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. JMP Securities lifted their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Finally, Robert W. Baird increased their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $524.85.

Axon Enterprise Stock Down 0.2 %

Shares of AXON opened at $652.18 on Friday. Axon Enterprise, Inc. has a 1 year low of $247.04 and a 1 year high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a 50 day simple moving average of $619.63 and a two-hundred day simple moving average of $481.39. The firm has a market cap of $49.73 billion, a P/E ratio of 168.52, a P/E/G ratio of 6.41 and a beta of 1.04.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.